Summary A study of parental cancer in 326 children referred to a single Paediatric Oncology Unit found a significant increase in breast cancer in mothers of children with solid tumours. The 5 tumours found were 8.9 times the expected number. This increase could not be accounted for by any of the known risk factors for breast cancer. The incidence of cancer in mothers of leukaemic children and in all groups of fathers was not significantly raised. Further prospective studies in the mothers of young children with soft tissue tumours are needed to clarify the groups at risk and to determine whether counselling and surveillance of these mothers is appropriate.
Childhood malignancies are a heterogeneous group with a variable aetiology based on genetic, familial, environmental and immunological events (Kramer et al., 1983; Jensen & Miller, 1971; Fraumeni & Glass, 1968; Li, 1978; Draper et al., 1977) . The observation of Li and Fraumeni (1969) of the association of sarcoma in children and early onset cancers in close relatives, particularly mothers, has been validated by years of follow up (1982) . A recent report by Birch et al. (1984) (Waterhouse et al., 1982) . The expected number of cases in each parental group was calculated by summing the individual parental expected numbers. The probability that the number of cancers occurring would be equal to or greater than that actually observed was calculated using a Poisson distribution with a mean equal to the expected number (Zar, 1974) .
Results
With the exception of one possible SBLA (sarcoma, breast, brain, laryngeal, lung, adrenocortical cancer and leukaemia, Lynch et al., 1978) family (no. 18), there were no cases of known familial cancer (multiple endocrine neoplasia, polyposis coli). Four children had neurofibromatosis (NF) with subsequent malignancy, but no parental cancer, although one mother had NF herself. One child with ataxia telangectasia developed Hodgkin's disease but there was no family history of cancer. There were 7 sets of twins (1 identical) but no sibling involvement. The median age for mothers of leukaemic children was 38.8 years, interquartile range 34.4 44.5. For mothers of children with solid tumours the median age was 37.3 years, interquartile range 32.0-41.1. For fathers of leukaemic children the median age and interquartile range were 41.7 years, and 36.4-47.6, and for fathers of children with solid tumours, 40.1 years and 35.7-44.0.
In the 638 parents (326 mothers, 312 fathers), there were 18 cases of cancer median age, 37 years, 11 of whom died of their cancer (8 mothers and 3 fathers). There were 10 deaths (2 mothers and 8 fathers) in the group without cancer, median age 47, 6 from cardiovascular disease (1 mother, 5 fathers) and 4 were accidental. Table I gives details of parental tumours. The tumours in the mothers consisted of 8 adenocarcinomas of breast, 2 cervical squamous cancers and 1 yolk sac tumour of the ovary. All the breast cancers were of ductal type. There were no special types of breast cancer or bilateral tumours in the sample. In the fathers there were 2 adenocarcinomas of bowel (1 diagnosed at laparotomy without biopsy), 1 each of the following: cutaneous melanoma, renal adenocarcinoma, between mothers and fathers with or without cancer. There was no significant difference in the age of onset of cancer in the children whether a parent had cancer or not. The expected and actual number of cancers found in this study with the calculated relative risks are shown in Table II . There was an increased risk of breast cancer in mothers of children with malignancy (P=0.001), estimated risk 4.1 times. Dividing the mothers by childhood cancer type, showed an increased risk of breast cancer in mothers of children with leukaemia and lymphoma which was not statistically significant (P=0.16), estimated risk 2.2 times in contrast to a highly significant (P < 0.001) increased risk in mothers of children with solid tumours, estimated risk 8.9 times. Subdividing further by solid tumour type gives a significantly increased risk of breast cancer for mothers of children with rhabdomyosarcoma (P=0.002), estimated risk 33.3 times, and for mothers of children with neuroblastoma (P=0.001). There was no significant increase in the risk of cervical cancer. The risk of all tumours in the mothers reflected the breast cancer rate. There was no increase in cancer in the fathers.
There were two in-situ squamous cancers of the cervix, one benign lipoma and benign leiomyoma of the oesophagus, found in the parents, but not considered in this analysis.
Discussion
This study has shown a significant increase of breast cancer in mothers of young children with solid tumours. In all fathers and the mothers of children with haematological malignancies the risk was not increased.
Breast cancer in mothers of 2 of the 3 children with leukaemia (only one of whom was premenopausal) were from breast cancer families, in contrast to the solid tumour group where no such history was present. Only one family (no. 18) possibly fell into the SBLA group, the child with hypernephroma, father with an osteogenic sarcoma, grandfather with unknown cancer type and a 12 year old cousin with leukaemia. A previous population based study by Birch et al. (1984) only looked at the families of young children with soft tissue sarcomata predominantly rhabdomyosarcoma. They found the breast cancer incidence in the mothers of these children was significantly increased with results very similar to our own. Their study was larger and so they were able to subdivide the patients further showing an even greater risk for mothers of young boys with genitourinary tumours. Only one of our cases with rhabdomyosarcoma was male with a paratesticular tumour. His mother, aged 30, developed a breast cancer 9 years after the boy's tumour had been successfully treated.
We were not able to confirm the finding of Birch et al. (1984) that there was any increase in bilateral and special types of breast cancer. All our tumours were unilateral, none satisfied the conventional pathological criteria for any of the special types of breast cancer. This might be due to the fact that our numbers are small and only two of the five young children with solid tumour had rhabdomyosarcoma.
There are many factors which are known to increase the risk of breast cancer, increased age at first pregnancy and family history of breast cancer being the most prominent. Although we did not study the former variable in detail, the age at first pregnancy for the breast cancer mothers did not appear to be increased. We did not undertake a detailed pedigree family history on previous generations of these families, but knew that in two instances, maternal sisters or mothers also had a history of breast cancer. These were the two older children with leukaemia.
There is always a danger in using population-based morbidity data as a control, as many uncontrolled variables are present, such as family history of breast cancer, age of the mother at first pregnancy, domicile, smoking habits, all of which may increase the risks of cancer. Because the study was retrospective, there was always the danger that it is easier to find the data on unusual cases, such as parents with cancer, and so bias the figures towards an increased risk. It is also possible that cancers may have been missed, because if one parent died there would be a greater chance of the family moving out of the area. The best way of overcoming these problems would be to investigate a case controlled study matching the known variables affecting breast cancer. There are many theories which can account for our findings, which may have a heritable component, or an environmental factor affecting mother and child. Further genetic studies are needed to clarify these points. However, we feel that the risk of maternal cancer, particularly breast cancer, is higher than expected in mothers of young children with solid tumours, but not leukaemia, which is a much commoner childhood cancer. Such cancers may present years after the child's illness. The need to study the mothers of these children prospectively is important to determine whether counselling or regular surveillance monitoring of these mothers is justified or not.
